Selenium, zinc, and copper plasma levels in patients with schizophrenia: Relationship with metabolic risk factors

Biological Trace Element Research

Volumn 156, Issue 1-3, 2013, Pages 22-28

  Vidović, Bojana ^a   Crossed D Signorcrossed D Signević, Brižita ^a   Milovanović, Srcrossed D Signan ^a,b   Škrivanj, Sandra ^c   Pavlović, Zoran ^d   Stefanović, Aleksandra ^a   Kotur Stevuljević, Jelena ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Medical Faculty   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d Institute for Public Health Po arevac   (Serbia)

Author keywords

Copper; Metabolic syndrome; Schizophrenia; Selenium; Zinc

Indexed keywords

ANXIOLYTIC AGENT; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; COPPER; GLUCOSE; MOOD STABILIZER; OLANZAPINE; RISPERIDONE; SELENIUM; TRIACYLGLYCEROL; ZINC;

ADULT; ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; CORRELATIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; RISK FACTOR; SCHIZOPHRENIA; SELENIUM BLOOD LEVEL; WAIST CIRCUMFERENCE; ZINC BLOOD LEVEL;

ADULT; COPPER; FASTING; FEMALE; HUMANS; MALE; RISK FACTORS; SCHIZOPHRENIA; SELENIUM; ZINC;

EID: 84890803241     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-013-9842-1     Document Type: Article

References (46)

1. Laursen TM, Munk-Olsen T, Vestergaard M (2012) Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatry 25:83-88
2. Casey DA, Rodriguez M, Northcott C, Vickar G, Shihabuddin L (2011) Schizophrenia: medical illness, mortality, and aging. Int J Psychiatry Med 41:245-251
3. Hert MD, Dekker JM, Wood D, Kahl KG, Möller HJ (2009) Cardiovascular disease and diabetes in people with severe mental illness. Rev Psiquiatr Salud Ment 2:49-59
4. Papanastasiou E (2013) The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review. Ther Adv Psychopharmacol 3:33-51
5. Ceriello A, Motz E (2004) Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24:816-823
6. Roberts CK, Sindhu KK (2009) Oxidative stress and metabolic syndrome. Life Sci 84:705-712
7. Kudrin AV (2000) Trace elements in regulation of NF-kB activity. J Trace Elem Med Biol 14:129-142
8. Ford ES, Mokdad AH, Giles WH, Brown DW (2003) The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 52:2346-2352
9. Arnaud J, de Lorgeril M, Akbaraly T, Salen P, Arnout J, Cappuccio FP, van Dongen MC, Donati MB, Krogh V, Siani A, Iacoviello L, European Collaborative Group of the IMMIDIET Project (2012) Gender differences in copper, zinc and selenium status in diabetic-free metabolic syndrome European population - the IMMIDIET study. Nutr Metab Cardiovasc Dis 22:517-524
10. Pizent A, Pavlovic M, Jurasovic J, Dodig S, Pasalic D, Mujagic R (2010) Antioxidants, trace elements and metabolic syndrome in elderly subjects. J Nutr Health Aging 14:866-871
11. Obeid O, Elfakhani M, Hlais S, Iskandar M, Batal M, Mouneimne Y, Adra N, Hwalla N (2008) Plasma copper, zinc, and selenium levels and correlates with metabolic syndrome components of Lebanese adults. Biol Trace Elem Res 123:58-65
12. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome - a new worldwide definition. Lancet 366:1059-1062
13. Bland JM, Altman DG (1996) Statistics notes: transformations, means, and confidence intervals. BMJ 312:1079
14. Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ (2010) International consensus study of antipsychotic dosing. Am J Psychiatry 167:686-693
15. Lindenmayer JP, Czobor P, Volavka J, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M, Lieberman JA (2003) Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. Am J Psychiatry 160:290-296
16. Newcomer W (2005) Metabolic risk during antipsychotic treatment. Clin Ther 26:1936-1946
17. Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, De Hert M (2013) Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders - a systematic review and meta-analysis. Schizophr Bull 39:306-318
18. Pfeiffer CC, Iliev V (1972) A study of zinc deficiency and copper excess in the schizophrenias. Int Rev Neurobiol 1:141-165
19. Yanik M, Kocyigit A, Tutkun H, Vural H, Herken H (2004) Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia. Biol Trace Elem Res 98:109-117
20. Herrán A, García-Unzueta MT, Fernández- González MD, Vázquez-Barquero JL, Alvarez C, Amado JA (2000) Higher levels of serum copper in schizophrenic patients treated with depot neuroleptics. Psychiatr Res 94:51-58
21. Nechifor M, Vaideanu C, Palamaru I, Borza C, Mindreci I (2004) The influence of some antipsychotics on erythrocyte magnesium and plasma magnesium, calcium, copper and zinc in patients with paranoid schizophrenia. J Am Coll Nutr 23:549S-551S
22. Crammer JL (1983) Trace elements in neuropsychiatry. Br J Psychiatry 143:85-88
23. Bowman MB, Lewis MS (1982) The copper hypothesis of schizophrenia: a review. Neurosci Biobehav 6:321-328
24. Bo S, Durazzo M, Gambino R, Berutti C, Milanesio N, Caropreso A, Gentile L, Cassader M, Cavallo-Perin P, Pagano G (2008) Associations of dietary and serum copper with inflammation, oxidative stress, and metabolic variables in adults. J Nutr 138:305-310
25. Aguilar MV, Saavedra P, Arrieta FJ, Mateos CJ, González MJ, Meseguer I, Martínez-Para MC (2007) Plasma mineral content in type-2 diabetic patients and their association with the metabolic syndrome. Ann Nutr Metab 51(5):402-406
26. Bitanihirwe BK, Cunningham MG (2009) Zinc: the brain's dark horse. Synapse 63:1029
27. Ogundahunsi OA, Duduyemi OO, Soyinka OO (2011) Effects of antipsychotic drugs on the levels of selected trace elements in schizophrenia. Afr Sci 12:77-82
28. Arinola OG, Idonije OB (2009) Status of plasma nitric oxide and non-enzymatic antioxidants before and after antipsychotic treatment in Nigerian patients with schizophrenia. J Res Med Sci 14:37-42
29. Craven C, Duggan PF, Buckley N, Gaughran F (1997) Serum zinc levels in patients with schizophrenia and their mothers. Schizophr Res 26:83-84
30. Rayman MP (2012) Selenium and human health. Lancet 379:1256-1268
31. Rayman MP, Stranges S (2013) Epidemiology of selenium and type 2 diabetes: can we make sense it? Free Radic Biol Med. doi: 10.1016/j. freeradbiomed.2013.04.003
32. Maksimović ZJ, Djujić I, Jović V, Rsumović M (1992) Selenium deficiency in Yugoslavia. Biol Trace Elem Res 33:187-196
33. Mihajlovic MB, Vasiljevic Z, Sobajic S, Jovanovic IB, Pesut O, Matic G (2003) Antioxidant status of patients with acute myocardial infarction. Trace Elem Electrolyte 20:5-7
34. Pesut O, Backovic D, Sobajic S (2005) Dietary selenium supplementation of pigs and broilers as a way of producing selenium enriched meat. Acta Vet (Beograd) 55:483-492
35. Pavlović Z, Miletic I, Jokic Z, Stevanovic J, Sobajic S, Bulat Z (2013) The influence of selenium supplementation of animal feed on human selenium intake in Serbia. Biotech Anim Husb 29:345-352
36. Duffield AJ, Thomson CD, Hill KE, Williams S (1999) An estimation of selenium requirements for New Zealanders. Am J Clin Nutr 70:896-903
37. Vaddadi KS, Soosai E, Vaddadi G (2003) Low blood selenium concentrations in schizophrenic patients on clozapine. Br J Clin Pharmacol 55:307-309
38. Alertsen AR, Aukrust A, Skaug OE (1986) Selenium concentration in blood and serum from patients with mental diseases. Acta Psychiatr Scand 74:217-219
39. Yang KC, Lee LT, Lee YS, Huang HY, Chen CY, Huang KC (2010) Serum selenium concentration is associated with metabolic factors in the elderly: a cross-sectional study. Nutr Metab (Lond) 7:38
40. Stranges S, Laclaustra M, Ji C, Cappuccio FP, Navas-Acien A, Ordovas JM, Rayman M, Guallar E (2010) Higher selenium status is associated with adverse blood lipid profile in British adults. J Nutr 140:81-87
41. Ghayour-Mobarhan M, Taylor A, Lanham-New S, Lamb DJ, Nezhad MA, Kazemi-Bajestani SMR, Ghafouri F, Livingstone C, Wang T, Ferns GAA (2008) Serum selenium and glutathione peroxidase in patients with obesity and metabolic syndrome. Pak J Nutr 7:112-117
42. Burk RF, Hill KE (1993) Regulation of selenoproteins. Annu Rev Nutr 13:65-81
43. Fairweather-Tait SJ, Bao Y, Broadley MR, Collings R, Ford D, Hesketh JE, Hurst R (2011) Selenium in human health and disease. Antioxid Redox Signal 14:1337-1383
44. Yang SJ, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM (2011) Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J Clin Endocrinol Metabol 96:E1325-E1329
45. Steinbrenner H, Speckmann B, Pinto A, Sies H (2011) High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism. J Clin Biochem Nutr 48:40-45
46. Yubero-Serrano EM, Delgado-Lista J, Peña-Orihuela P et al (2013) Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study. Exp Mol Med 45:e28. doi: 10.1038/emm.2013.53